Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Financière de Tubize SA: Annual financial Report

Financière de Tubize SA
Posted on: 22 Feb 18

Press release

22 February 2018 - 8:00h CET  


Allée de la Recherche 60, 1070 Brussels

Contact: Anne Sophie Pijcke, directeur,


Annual financial report 2017

Regulated information

22 February 2018

The board of directors of Financière de Tubize has established the 2018 annual financial report. This report is available on the website

  • Dividend received from UCB: € 78,3 million (against € 74.9 million in 2016)
  • Profit of € 72,7 million (against € 69.0 million in 2016)
  • Decrease of outstanding debt from € 241 million at 31 December 2016 to € 192 million at 31 December 2017.

If the general shareholders meeting of 25 April 2018 approves the 2017 annual accounts, including the proposed result appropriation, a dividend of € 0,54 will be payable as from 4 th of May 2018 onwards at the offices, seats and branches of BNP Paribas Fortis, in exchange of coupon n° 13.

Ex-dividend                         2 May 2018

Record date                       3 May 2018

Payment date                    4 May 2018

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Financière de Tubize SA via GlobeNewswire

Last updated on: 23/02/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.